Michael A. Fauman
Impact in
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Toxicology top 10%
Papers in
-
- Psychosomatic Disorders and Their Treatments 5
- Co-authors
- Godfrey S. Getz (1 shared paper)Peter Rosén (1 shared paper)Murray Rabinowitz (3 shared papers)Hewson H. Swift (1 shared paper)Michael H. Allen (1 shared paper)Stephen F. Morin (1 shared paper)
- Journals
- American Journal of Psychiatry (6 papers)Psychiatric Clinics of North America (2 papers)JAMA (1 paper)Biological Psychiatry (1 paper)FEBS Letters (1 paper)
- Partner nations
- United States
In The Last Decade
Michael A. Fauman
29 papers receiving 491 citations
Peers
Comparison fields: 5 of 102
- Psychiatry and Mental health 119
- Toxicology 23
- Social Psychology 129
- Clinical Psychology 116
- Biological Psychiatry 13
Countries citing papers authored by Michael A. Fauman
This map shows the geographic impact of Michael A. Fauman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Fauman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Fauman more than expected).
Fields of papers citing papers by Michael A. Fauman
This network shows the impact of papers produced by Michael A. Fauman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Fauman. The network helps show where Michael A. Fauman may publish in the future.
Co-authors
The 6 scholars most cited alongside Michael A. Fauman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 69 | |
| 2 | 2008 | 68 | |
| 3 | 1969 | 60 | |
| 4 | 1989 | 37 | |
| 5 | The psychiatric aspects of chronic phencyclidine use: a study of chronic PCP users. | 1978 | 33 |
| 6 | 1983 | 31 | |
| 7 | 1979 | 30 | |
| 8 | 1978 | 27 | |
| 9 | 1977 | 26 | |
| 10 | 1980 | 26 | |
| 11 | 1981 | 25 | |
| 12 | 1987 | 25 | |
| 13 | Study Guide to DSM-IV | 1994 | 14 |
| 14 | 1973 | 11 | |
| 15 | 1974 | 11 | |
| 16 | 1972 | 10 | |
| 17 | 1990 | 10 | |
| 18 | 1980 | 9 | |
| 19 | Chronic phenycyclidine (PCP) abuse: a psychiatric perspective--Part II: Psychosis [proceedings]. | 1980 | 9 |
| 20 | 1983 | 7 |
About Michael A. Fauman
Michael A. Fauman is a scholar working on Molecular Biology, Psychiatry and Mental health, General Health Professions, Clinical Psychology and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 570 indexed citations. Recurring topics across this work include Psychosomatic Disorders and Their Treatments (5 papers), Mental Health and Psychiatry (3 papers), Forensic Toxicology and Drug Analysis (3 papers), Metabolism and Genetic Disorders (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Psychedelics and Drug Studies (2 papers), Healthcare professionals’ stress and burnout (2 papers) and Chemical synthesis and alkaloids (2 papers). The work is most often cited by research in Psychiatry and Mental health (119 citations), Toxicology (23 citations), Social Psychology (129 citations), Clinical Psychology (116 citations) and Biological Psychiatry (13 citations). Michael A. Fauman has collaborated with scholars based in United States. Frequent co-authors include Godfrey S. Getz, Peter Rosén, Murray Rabinowitz, Hewson H. Swift, Michael H. Allen and Stephen F. Morin. Their work appears in journals such as American Journal of Psychiatry, Psychiatric Clinics of North America, JAMA, Biological Psychiatry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.